| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | NANOGP8 USP51 ATRX NANOG MPHOSPH8 CHD6 SSRP1 BRD1 DEK L3MBTL3 | 2.11e-08 | 265 | 68 | 10 | GO:0042393 |
| GeneOntologyMolecularFunction | chromatin binding | NANOGP8 USP51 ATRX NANOG RBPJ H1-0 H1-2 H1-6 MPHOSPH8 CHD6 SSRP1 FANCM L3MBTL3 | 1.05e-06 | 739 | 68 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 6.83e-05 | 4 | 68 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.20e-04 | 753 | 68 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | histone deubiquitinase activity | 3.16e-04 | 8 | 68 | 2 | GO:0140934 | |
| GeneOntologyMolecularFunction | nucleosome binding | 3.49e-04 | 98 | 68 | 4 | GO:0031491 | |
| GeneOntologyMolecularFunction | retromer complex binding | 5.05e-04 | 10 | 68 | 2 | GO:1905394 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 6.85e-04 | 206 | 68 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor activity | 7.41e-04 | 52 | 68 | 3 | GO:0016251 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 9.28e-04 | 127 | 68 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.55e-03 | 67 | 68 | 3 | GO:0031492 | |
| GeneOntologyMolecularFunction | general transcription initiation factor activity | 1.62e-03 | 68 | 68 | 3 | GO:0140223 | |
| GeneOntologyMolecularFunction | helicase activity | 2.07e-03 | 158 | 68 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.54e-03 | 167 | 68 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 2.76e-03 | 23 | 68 | 2 | GO:0010314 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 3.37e-03 | 88 | 68 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | histone reader activity | 3.52e-03 | 26 | 68 | 2 | GO:0140566 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.87e-03 | 441 | 68 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 4.67e-03 | 30 | 68 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.81e-03 | 614 | 68 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 4.83e-03 | 100 | 68 | 3 | GO:0030527 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.99e-03 | 31 | 68 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 4.99e-03 | 31 | 68 | 2 | GO:0080025 | |
| GeneOntologyMolecularFunction | actin binding | 5.76e-03 | 479 | 68 | 6 | GO:0003779 | |
| GeneOntologyMolecularFunction | spectrin binding | 5.98e-03 | 34 | 68 | 2 | GO:0030507 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 6.32e-03 | 35 | 68 | 2 | GO:0043325 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 6.68e-03 | 36 | 68 | 2 | GO:0070273 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 7.05e-03 | 37 | 68 | 2 | GO:0140658 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | USP36 BDP1 KMT2C TAF3 UBN1 USP51 ATRX TAF7L H1-0 H1-2 H1-6 MPHOSPH8 CHD6 SSRP1 BRD1 DDX21 DEK L3MBTL3 | 1.82e-09 | 999 | 67 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | USP36 KMT2C UBN1 USP51 ATRX H1-0 H1-2 H1-6 MPHOSPH8 CHD6 SSRP1 BRD1 DDX21 DEK L3MBTL3 | 1.13e-08 | 741 | 67 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 1.10e-07 | 249 | 67 | 9 | GO:0065004 | |
| GeneOntologyBiologicalProcess | chromatin organization | USP36 KMT2C UBN1 USP51 ATRX H1-0 H1-2 H1-6 MPHOSPH8 CHD6 SSRP1 BRD1 DDX21 DEK L3MBTL3 | 1.37e-07 | 896 | 67 | 15 | GO:0006325 |
| GeneOntologyBiologicalProcess | nucleosome assembly | 2.81e-06 | 122 | 67 | 6 | GO:0006334 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 6.77e-06 | 142 | 67 | 6 | GO:0034728 | |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase III | 5.24e-05 | 63 | 67 | 4 | GO:0006383 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 6.21e-05 | 4 | 67 | 2 | GO:0042664 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 6.74e-05 | 131 | 67 | 5 | GO:0032526 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 1.03e-04 | 5 | 67 | 2 | GO:0042663 | |
| GeneOntologyBiologicalProcess | barbed-end actin filament capping | 1.13e-04 | 29 | 67 | 3 | GO:0051016 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 1.28e-04 | 150 | 67 | 5 | GO:0000018 | |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 1.38e-04 | 31 | 67 | 3 | GO:0034315 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 1.55e-04 | 6 | 67 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | DNA recombination | 1.88e-04 | 368 | 67 | 7 | GO:0006310 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 2.02e-04 | 89 | 67 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 2.87e-04 | 8 | 67 | 2 | GO:0009996 | |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 2.97e-04 | 40 | 67 | 3 | GO:1902275 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 3.15e-04 | 100 | 67 | 4 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 3.20e-04 | 41 | 67 | 3 | GO:0051125 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 3.80e-04 | 105 | 67 | 4 | GO:1901879 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 4.21e-04 | 194 | 67 | 5 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 4.25e-04 | 421 | 67 | 7 | GO:0010639 | |
| GeneOntologyBiologicalProcess | actin filament capping | 4.50e-04 | 46 | 67 | 3 | GO:0051693 | |
| GeneOntologyBiologicalProcess | nuclear DNA replication | 4.50e-04 | 46 | 67 | 3 | GO:0033260 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 4.51e-04 | 197 | 67 | 5 | GO:1902904 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 4.60e-04 | 10 | 67 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | Arp2/3 complex-mediated actin nucleation | 4.80e-04 | 47 | 67 | 3 | GO:0034314 | |
| GeneOntologyBiologicalProcess | chromosome condensation | 5.10e-04 | 48 | 67 | 3 | GO:0030261 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 5.61e-04 | 11 | 67 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | cell cycle DNA replication | 6.10e-04 | 51 | 67 | 3 | GO:0044786 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 6.46e-04 | 52 | 67 | 3 | GO:0030835 | |
| GeneOntologyBiologicalProcess | cellular response to hydroxyurea | 6.72e-04 | 12 | 67 | 2 | GO:0072711 | |
| GeneOntologyBiologicalProcess | dense core granule cytoskeletal transport | 6.72e-04 | 12 | 67 | 2 | GO:0099519 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | 6.72e-04 | 1081 | 67 | 11 | GO:0006259 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 7.62e-04 | 55 | 67 | 3 | GO:0045910 | |
| GeneOntologyBiologicalProcess | response to hydroxyurea | 7.92e-04 | 13 | 67 | 2 | GO:0072710 | |
| GeneOntologyBiologicalProcess | dense core granule transport | 9.22e-04 | 14 | 67 | 2 | GO:1901950 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 9.27e-04 | 231 | 67 | 5 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 1.03e-03 | 61 | 67 | 3 | GO:0030834 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 1.06e-03 | 15 | 67 | 2 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 1.06e-03 | 15 | 67 | 2 | GO:0043696 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | USP36 WASHC2C ATRX MAP1B SYT4 MPHOSPH8 WASHC2A DNAI3 ARMH3 ADD1 ADD2 SPICE1 | 1.17e-03 | 1342 | 67 | 12 | GO:0033043 |
| GeneOntologyBiologicalProcess | actin nucleation | 1.24e-03 | 65 | 67 | 3 | GO:0045010 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.24e-03 | 144 | 67 | 4 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.24e-03 | 144 | 67 | 4 | GO:0043244 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 1.30e-03 | 66 | 67 | 3 | GO:0030042 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 1.37e-03 | 17 | 67 | 2 | GO:0010454 | |
| GeneOntologyBiologicalProcess | cytosolic transport | 1.44e-03 | 150 | 67 | 4 | GO:0016482 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 1.54e-03 | 18 | 67 | 2 | GO:0001711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 1.54e-03 | 18 | 67 | 2 | GO:2000035 | |
| GeneOntologyBiologicalProcess | chromosome organization | 1.66e-03 | 686 | 67 | 8 | GO:0051276 | |
| GeneOntologyCellularComponent | chromatin | FANCD2 NANOGP8 ATRX NANOG RBPJ H1-0 H1-2 H1-6 MPHOSPH8 CHD6 SSRP1 BRD1 FANCM DDX21 DEK | 7.80e-05 | 1480 | 69 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | B-WICH complex | 2.97e-04 | 8 | 69 | 2 | GO:0110016 | |
| GeneOntologyCellularComponent | F-actin capping protein complex | 3.81e-04 | 9 | 69 | 2 | GO:0008290 | |
| GeneOntologyCellularComponent | WASH complex | 1.10e-03 | 15 | 69 | 2 | GO:0071203 | |
| GeneOntologyCellularComponent | nucleosome | 1.13e-03 | 138 | 69 | 4 | GO:0000786 | |
| HumanPheno | Short palpebral fissure | 2.45e-06 | 122 | 18 | 6 | HP:0012745 | |
| HumanPheno | Abnormal pulmonary valve cusp morphology | 7.05e-05 | 4 | 18 | 2 | HP:0031566 | |
| HumanPheno | Finger clinodactyly | 7.11e-05 | 452 | 18 | 8 | HP:0040019 | |
| HumanPheno | Toe syndactyly | 1.30e-04 | 244 | 18 | 6 | HP:0001770 | |
| HumanPheno | Abnormal 5th finger morphology | 1.66e-04 | 509 | 18 | 8 | HP:0004207 | |
| HumanPheno | Hypoplastic philtrum | 1.75e-04 | 6 | 18 | 2 | HP:0005326 | |
| HumanPheno | Deviation of finger | 2.43e-04 | 537 | 18 | 8 | HP:0004097 | |
| HumanPheno | Short long bone | 2.66e-04 | 278 | 18 | 6 | HP:0003026 | |
| HumanPheno | Abnormality of refraction | 2.79e-04 | 709 | 18 | 9 | HP:0000539 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | 3.42e-04 | 564 | 18 | 8 | HP:0009484 | |
| HumanPheno | Clinodactyly of the 5th finger | 3.52e-04 | 420 | 18 | 7 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 3.57e-04 | 421 | 18 | 7 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 3.57e-04 | 421 | 18 | 7 | HP:0009179 | |
| HumanPheno | Clinodactyly | 3.87e-04 | 574 | 18 | 8 | HP:0030084 | |
| HumanPheno | Abnormal size of the palpebral fissures | 3.89e-04 | 298 | 18 | 6 | HP:0200007 | |
| HumanPheno | Talipes | 4.31e-04 | 583 | 18 | 8 | HP:0001883 | |
| HumanPheno | Positional foot deformity | 4.52e-04 | 587 | 18 | 8 | HP:0005656 | |
| MousePheno | embryonic lethality prior to tooth bud stage | USP36 BDP1 EPRS1 NANOGP8 MAP1B ATAD5 ANLN NANOG RBPJ RPS19BP1 MPHOSPH8 SNAPC1 SSRP1 POLR1G DDX21 STT3B KIAA0753 | 1.74e-05 | 1383 | 56 | 17 | MP:0013293 |
| MousePheno | embryonic lethality prior to organogenesis | USP36 BDP1 EPRS1 NANOGP8 MAP1B ATAD5 ANLN NANOG RBPJ RPS19BP1 SNAPC1 SSRP1 POLR1G DDX21 KIAA0753 | 5.39e-05 | 1204 | 56 | 15 | MP:0013292 |
| Domain | Histone_H5 | 2.23e-06 | 8 | 65 | 3 | IPR005819 | |
| Domain | H15 | 1.12e-05 | 13 | 65 | 3 | SM00526 | |
| Domain | Linker_histone | 1.12e-05 | 13 | 65 | 3 | PF00538 | |
| Domain | H15 | 1.12e-05 | 13 | 65 | 3 | PS51504 | |
| Domain | Ribosomal_L44e | 1.19e-05 | 2 | 65 | 2 | IPR000552 | |
| Domain | Ribosomal_L44 | 1.19e-05 | 2 | 65 | 2 | PF00935 | |
| Domain | Ribosomal_L44e | 1.19e-05 | 2 | 65 | 2 | PD002841 | |
| Domain | RIBOSOMAL_L44E | 1.19e-05 | 2 | 65 | 2 | PS01172 | |
| Domain | FAM21 | 1.19e-05 | 2 | 65 | 2 | IPR027308 | |
| Domain | - | 1.19e-05 | 2 | 65 | 2 | 3.10.450.80 | |
| Domain | Histone_H1/H5_H15 | 1.42e-05 | 14 | 65 | 3 | IPR005818 | |
| Domain | FAM21/CAPZIP | 3.57e-05 | 3 | 65 | 2 | IPR029341 | |
| Domain | CAP-ZIP_m | 3.57e-05 | 3 | 65 | 2 | PF15255 | |
| Domain | Aldolase_II/adducin_N | 7.12e-05 | 4 | 65 | 2 | IPR001303 | |
| Domain | Aldolase_II | 7.12e-05 | 4 | 65 | 2 | PF00596 | |
| Domain | - | 7.12e-05 | 4 | 65 | 2 | 3.40.225.10 | |
| Domain | Aldolase_II | 7.12e-05 | 4 | 65 | 2 | SM01007 | |
| Domain | - | 1.59e-04 | 449 | 65 | 8 | 3.30.40.10 | |
| Domain | Znf_FYVE_PHD | 1.59e-04 | 147 | 65 | 5 | IPR011011 | |
| Domain | Znf_RING/FYVE/PHD | 1.85e-04 | 459 | 65 | 8 | IPR013083 | |
| Domain | ZF_PHD_2 | 3.35e-04 | 95 | 65 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 3.49e-04 | 96 | 65 | 4 | PS01359 | |
| Domain | Ribosomal_zn-bd | 4.23e-04 | 9 | 65 | 2 | IPR011332 | |
| Domain | Helicase_C | 5.27e-04 | 107 | 65 | 4 | PF00271 | |
| Domain | HELICc | 5.27e-04 | 107 | 65 | 4 | SM00490 | |
| Domain | Helicase_C | 5.46e-04 | 108 | 65 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 5.65e-04 | 109 | 65 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.65e-04 | 109 | 65 | 4 | PS51192 | |
| Domain | DEXDc | 5.65e-04 | 109 | 65 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.85e-04 | 110 | 65 | 4 | IPR014001 | |
| Domain | PHD | 2.27e-03 | 75 | 65 | 3 | PF00628 | |
| Domain | EPHD | 2.63e-03 | 22 | 65 | 2 | PS51805 | |
| Domain | Znf_PHD-finger | 2.63e-03 | 79 | 65 | 3 | IPR019787 | |
| Domain | Chromo_domain | 3.13e-03 | 24 | 65 | 2 | IPR023780 | |
| Domain | Chromo | 3.67e-03 | 26 | 65 | 2 | PF00385 | |
| Domain | PHD | 3.69e-03 | 89 | 65 | 3 | SM00249 | |
| Domain | Znf_PHD | 3.93e-03 | 91 | 65 | 3 | IPR001965 | |
| Domain | CHROMO_1 | 4.25e-03 | 28 | 65 | 2 | PS00598 | |
| Domain | CHROMO_2 | 4.25e-03 | 28 | 65 | 2 | PS50013 | |
| Domain | SNF2_N | 5.53e-03 | 32 | 65 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 5.53e-03 | 32 | 65 | 2 | IPR016197 | |
| Domain | SNF2_N | 5.53e-03 | 32 | 65 | 2 | PF00176 | |
| Domain | Chromo/shadow_dom | 5.87e-03 | 33 | 65 | 2 | IPR000953 | |
| Domain | CHROMO | 5.87e-03 | 33 | 65 | 2 | SM00298 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 6.59e-03 | 35 | 65 | 2 | IPR002464 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 1.35e-05 | 15 | 45 | 3 | MM14902 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 2.00e-05 | 17 | 45 | 3 | M27189 | |
| Pathway | REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME | 7.12e-05 | 70 | 45 | 4 | M27008 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 1.16e-04 | 30 | 45 | 3 | MM15173 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.26e-04 | 81 | 45 | 4 | M865 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.39e-04 | 83 | 45 | 4 | MM15314 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | BDP1 ELOA TAF3 TAF7L RBPJ SNAPC1 SSRP1 BRD1 POLR1G DDX21 DEK | 2.83e-04 | 1022 | 45 | 11 | MM15436 |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 5.05e-04 | 49 | 45 | 3 | MM15448 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 5.51e-04 | 119 | 45 | 4 | MM14901 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 6.02e-04 | 52 | 45 | 3 | M2341 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 6.44e-04 | 12 | 45 | 2 | MM14554 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 6.73e-04 | 54 | 45 | 3 | MM14904 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 7.60e-04 | 13 | 45 | 2 | M1018 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 9.34e-04 | 360 | 45 | 6 | M27267 | |
| Pathway | WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME | 9.61e-04 | 61 | 45 | 3 | M48077 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 1.01e-03 | 62 | 45 | 3 | M27618 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.16e-03 | 65 | 45 | 3 | M39682 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.24e-03 | 254 | 45 | 5 | M27131 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 1.28e-03 | 149 | 45 | 4 | M4076 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.55e-03 | 157 | 45 | 4 | MM15226 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY | 1.65e-03 | 19 | 45 | 2 | M47853 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.66e-03 | 160 | 45 | 4 | M27498 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 2.03e-03 | 79 | 45 | 3 | M27191 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.61e-03 | 301 | 45 | 5 | MM15983 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.72e-03 | 304 | 45 | 5 | MM14960 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 2.85e-03 | 25 | 45 | 2 | MM15172 | |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | 2.94e-03 | 90 | 45 | 3 | M29668 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 3.08e-03 | 26 | 45 | 2 | M27424 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | 3.08e-03 | 26 | 45 | 2 | MM15458 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 3.13e-03 | 92 | 45 | 3 | M27636 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 3.13e-03 | 92 | 45 | 3 | MM15338 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 3.52e-03 | 197 | 45 | 4 | M27188 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | 3.57e-03 | 28 | 45 | 2 | M1022 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | USP36 EPRS1 KMT2C ZNF148 RPL36A UBN1 ATRX ATAD5 RBPJ H1-0 H1-2 H1-6 MPHOSPH8 CHD6 SSRP1 FANCM POLR1G DDX21 DEK L3MBTL3 STT3B KNOP1 | 4.68e-15 | 1294 | 70 | 22 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 EPRS1 ELOA TAF3 ZNF148 UBN1 ATRX MAP1B ATAD5 ANLN RTF2 H1-2 MPHOSPH8 SSRP1 FANCM DDX21 DEK L3MBTL3 KNOP1 | 3.02e-14 | 954 | 70 | 19 | 36373674 |
| Pubmed | KMT2C TAF3 ZNF148 ATRX RBPJ H1-0 RPS19BP1 CHD6 SSRP1 PARP14 DEK L3MBTL3 KNOP1 | 9.76e-12 | 469 | 70 | 13 | 27634302 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ELOA TAF3 ZNF148 UBN1 ATRX ATAD5 ANLN RBPJ MPHOSPH8 CHD6 SSRP1 BRD1 DEK KNOP1 | 1.69e-11 | 608 | 70 | 14 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FANCD2 EPRS1 ELOA TAF3 ZNF148 WASHC2C UBN1 ATRX ANLN KIF1B SSRP1 POLR1G DDX21 ADD1 SPICE1 | 3.30e-11 | 774 | 70 | 15 | 15302935 |
| Pubmed | EPRS1 ELOA RPL36AL RPL36A ATRX MAP1B TRO H1-0 H1-2 H1-6 MPHOSPH8 CHD6 SSRP1 DDX21 KIAA2012 STT3B KNOP1 | 2.82e-09 | 1442 | 70 | 17 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 EPRS1 ELOA PTPN13 ZNF148 RPL36A WASHC2C ATRX MAP1B ATAD5 TACC2 DDX21 ADD1 KNOP1 | 4.41e-09 | 934 | 70 | 14 | 33916271 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 TAF3 RPL36AL ZNF148 RPL36A H1-0 H1-2 H1-6 CHD6 SSRP1 POLR1G DDX21 DEK ADD1 ADD2 KNOP1 | 5.95e-09 | 1318 | 70 | 16 | 30463901 |
| Pubmed | 2.02e-08 | 15 | 70 | 4 | 18400104 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ELOA TAF3 RPL36AL PTPN13 RPL36A MAP1B MPHOSPH8 CHD6 SSRP1 DDX21 DEK ADD2 STT3B KNOP1 | 2.79e-08 | 1082 | 70 | 14 | 38697112 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.45e-08 | 605 | 70 | 11 | 28977666 | |
| Pubmed | USP36 ELOA RPL36AL RPL36A H1-2 RPS19BP1 SSRP1 POLR1G DDX21 KNOP1 | 4.58e-08 | 483 | 70 | 10 | 36912080 | |
| Pubmed | UBN1 MAP1B ATAD5 ANLN RBPJ MPHOSPH8 CHD6 BRD1 L3MBTL3 SPICE1 KIAA0753 | 6.59e-08 | 645 | 70 | 11 | 25281560 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.14e-07 | 533 | 70 | 10 | 30554943 | |
| Pubmed | 1.50e-07 | 549 | 70 | 10 | 38280479 | ||
| Pubmed | EPRS1 KMT2C PTPN13 WASHC2C ATRX ANLN RBPJ LTN1 TACC2 DDX21 WASHC2A KIAA0753 KNOP1 | 2.23e-07 | 1084 | 70 | 13 | 11544199 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.71e-07 | 444 | 70 | 9 | 34795231 | |
| Pubmed | All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6. | 2.72e-07 | 7 | 70 | 3 | 8325638 | |
| Pubmed | FANCD2 USP36 TAF3 ZNF148 ATAD5 TAF7L H1-2 LTN1 SSRP1 BRD1 POLR1G FMNL2 KNOP1 | 3.11e-07 | 1116 | 70 | 13 | 31753913 | |
| Pubmed | Histone h1 depletion impairs embryonic stem cell differentiation. | 4.34e-07 | 8 | 70 | 3 | 22589736 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 5.21e-07 | 349 | 70 | 8 | 25665578 | |
| Pubmed | FANCD2 ELOA TAF3 UBN1 ATRX ATAD5 RTF2 H1-2 MPHOSPH8 SSRP1 POLR1G DEK | 7.94e-07 | 1014 | 70 | 12 | 32416067 | |
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 37012455 | ||
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 1.27e-06 | 11 | 70 | 3 | 26689747 | |
| Pubmed | PTPN13 ZNF148 RPL36A ATRX ATAD5 SSRP1 DDX21 WASHC2A DEK ADD1 ADD2 STT3B SPICE1 KIAA0753 | 1.31e-06 | 1487 | 70 | 14 | 33957083 | |
| Pubmed | 1.36e-06 | 94 | 70 | 5 | 16325481 | ||
| Pubmed | USP36 KMT2C RPL36AL PTPN13 ATRX ATAD5 ANLN LTN1 MPHOSPH8 CHD6 SSRP1 POLR1G STT3B KNOP1 | 1.42e-06 | 1497 | 70 | 14 | 31527615 | |
| Pubmed | 1.57e-06 | 711 | 70 | 10 | 33022573 | ||
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 1.70e-06 | 12 | 70 | 3 | 22650316 | |
| Pubmed | 1.97e-06 | 417 | 70 | 8 | 36537216 | ||
| Pubmed | 2.02e-06 | 731 | 70 | 10 | 29298432 | ||
| Pubmed | 2.04e-06 | 419 | 70 | 8 | 15635413 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | USP36 EPRS1 UBN1 MAP1B MYO9A ANLN RTF2 H1-0 H1-2 LTN1 SSRP1 POLR1G DDX21 | 2.66e-06 | 1353 | 70 | 13 | 29467282 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.76e-06 | 588 | 70 | 9 | 38580884 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.81e-06 | 759 | 70 | 10 | 35915203 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 RPL36AL RPL36A H1-0 H1-2 RPS19BP1 SSRP1 POLR1G DDX21 DEK STT3B | 2.93e-06 | 949 | 70 | 11 | 36574265 |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 3.43e-06 | 604 | 70 | 9 | 37616343 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12427140 | ||
| Pubmed | DNA-induced secondary structure of the carboxyl-terminal domain of histone H1. | 3.99e-06 | 2 | 70 | 2 | 16006555 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19423727 | ||
| Pubmed | Primary structure and domain organization of human alpha and beta adducin. | 3.99e-06 | 2 | 70 | 2 | 1840603 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10845937 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10529182 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15847701 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 36477367 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 3.99e-06 | 2 | 70 | 2 | 19415763 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20827171 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24598770 | ||
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 3.99e-06 | 2 | 70 | 2 | 22079639 | |
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 3.99e-06 | 2 | 70 | 2 | 36717248 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22334665 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17301826 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19838659 | ||
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 3.99e-06 | 2 | 70 | 2 | 21136380 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FANCD2 USP36 EPRS1 RPL36A ATRX RBPJ H1-0 H1-2 MPHOSPH8 SSRP1 DDX21 DEK STT3B | 4.67e-06 | 1425 | 70 | 13 | 30948266 |
| Pubmed | 4.85e-06 | 332 | 70 | 7 | 25693804 | ||
| Pubmed | 6.23e-06 | 18 | 70 | 3 | 28401892 | ||
| Pubmed | EPRS1 RPL36AL ZNF148 RPL36A WASHC2C SSRP1 POLR1G DDX21 DEK KNOP1 | 7.38e-06 | 847 | 70 | 10 | 35850772 | |
| Pubmed | 7.39e-06 | 19 | 70 | 3 | 23329831 | ||
| Pubmed | FANCD2 USP36 ELOA PTPN13 ATAD5 LTN1 DEK L3MBTL3 ADD2 SPICE1 KIAA0753 | 7.59e-06 | 1049 | 70 | 11 | 27880917 | |
| Pubmed | 8.19e-06 | 63 | 70 | 4 | 25680957 | ||
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 1.11e-05 | 248 | 70 | 6 | 27926873 | |
| Pubmed | 1.17e-05 | 22 | 70 | 3 | 26589352 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 19447925 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 1.20e-05 | 3 | 70 | 2 | 30814124 | |
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 1.20e-05 | 3 | 70 | 2 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 1.20e-05 | 3 | 70 | 2 | 17554338 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 1.20e-05 | 3 | 70 | 2 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 1.20e-05 | 3 | 70 | 2 | 18177668 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 15834281 | ||
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 1.20e-05 | 3 | 70 | 2 | 16259959 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 12609610 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24227785 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 1.20e-05 | 3 | 70 | 2 | 17211451 | |
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 1.20e-05 | 3 | 70 | 2 | 23770853 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 15502159 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 1.20e-05 | 3 | 70 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 1.20e-05 | 3 | 70 | 2 | 23054952 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 1.20e-05 | 3 | 70 | 2 | 24527385 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 18086680 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 17204467 | ||
| Pubmed | Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. | 1.20e-05 | 3 | 70 | 2 | 10485892 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 1.20e-05 | 3 | 70 | 2 | 19800316 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23200040 | ||
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 1.20e-05 | 3 | 70 | 2 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 1.20e-05 | 3 | 70 | 2 | 23329853 | |
| Pubmed | Assignment of the human beta-adducin gene (ADD2) to 2p13-p14 by in situ hybridization. | 1.20e-05 | 3 | 70 | 2 | 7490111 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 31628488 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 1.20e-05 | 3 | 70 | 2 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 1.20e-05 | 3 | 70 | 2 | 17352742 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 1.20e-05 | 3 | 70 | 2 | 25005472 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 16773043 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 1.20e-05 | 3 | 70 | 2 | 26733157 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23071603 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 1.20e-05 | 3 | 70 | 2 | 19582141 | |
| Interaction | H3C1 interactions | FANCD2 USP36 EPRS1 ELOA KMT2C TAF3 RPL36A UBN1 ATRX ATAD5 ANLN RTF2 RBPJ H1-0 H1-2 H1-6 MPHOSPH8 SSRP1 BRD1 POLR1G DEK L3MBTL3 KNOP1 | 5.63e-15 | 901 | 67 | 23 | int:H3C1 |
| Interaction | H3-3A interactions | FANCD2 EPRS1 ELOA KMT2C TAF3 ZNF148 UBN1 ATRX ATAD5 ANLN NANOG RBPJ H1-0 H1-2 H1-6 MPHOSPH8 SSRP1 BRD1 DEK KNOP1 | 2.20e-13 | 749 | 67 | 20 | int:H3-3A |
| Interaction | SMC5 interactions | USP36 EPRS1 ELOA TAF3 ZNF148 UBN1 ATRX MAP1B ATAD5 ANLN RTF2 H1-2 MPHOSPH8 SSRP1 FANCM DDX21 DEK L3MBTL3 KNOP1 | 3.50e-10 | 1000 | 67 | 19 | int:SMC5 |
| Interaction | H2BC12 interactions | FANCD2 USP36 EPRS1 ATRX MAP1B ANLN TRO H1-0 H1-2 H1-6 OSBPL9 KNOP1 | 6.17e-10 | 322 | 67 | 12 | int:H2BC12 |
| Interaction | ZNF330 interactions | USP36 ELOA TAF3 ZNF148 ATAD5 ANLN MPHOSPH8 SSRP1 BRD1 DDX21 DEK L3MBTL3 KNOP1 | 2.20e-09 | 446 | 67 | 13 | int:ZNF330 |
| Interaction | KAT6A interactions | ELOA TAF3 B3GLCT ZNF148 RPL36A ATRX H1-2 SSRP1 BRD1 POLR1G DEK STT3B KNOP1 | 1.09e-08 | 510 | 67 | 13 | int:KAT6A |
| Interaction | MECP2 interactions | ELOA TAF3 RPL36AL PTPN13 RPL36A ATRX MAP1B ANLN RBPJ H1-6 MPHOSPH8 CHD6 SSRP1 POLR1G DDX21 DEK ADD2 STT3B KNOP1 | 2.22e-08 | 1287 | 67 | 19 | int:MECP2 |
| Interaction | CENPA interactions | USP36 TAF3 ZNF148 ATRX ATAD5 H1-2 CHD6 SSRP1 DEK L3MBTL3 KNOP1 | 4.27e-08 | 377 | 67 | 11 | int:CENPA |
| Interaction | GNL2 interactions | FANCD2 USP36 ELOA RPL36AL ANLN H1-6 SNAPC1 POLR1G DDX21 ADD2 KNOP1 | 5.43e-08 | 386 | 67 | 11 | int:GNL2 |
| Interaction | H3C3 interactions | ELOA ZNF148 ATRX ATAD5 ANLN RBPJ MPHOSPH8 CHD6 SSRP1 BRD1 DEK KNOP1 | 7.43e-08 | 495 | 67 | 12 | int:H3C3 |
| Interaction | IFI16 interactions | USP36 ELOA ZNF148 RPL36A MAP1B ANLN H1-0 H1-2 MPHOSPH8 SSRP1 BRD1 DDX21 ADD1 KNOP1 | 7.43e-08 | 714 | 67 | 14 | int:IFI16 |
| Interaction | CBX3 interactions | FANCD2 ELOA ZNF148 ATRX ATAD5 ANLN NANOG RBPJ RPS19BP1 SSRP1 BRD1 DEK KNOP1 | 1.73e-07 | 646 | 67 | 13 | int:CBX3 |
| Interaction | MEN1 interactions | FANCD2 EPRS1 KMT2C RPL36AL ZNF148 RPL36A WASHC2C ATRX ANLN NANOG SSRP1 POLR1G PARP14 DDX21 DEK KNOP1 | 1.82e-07 | 1029 | 67 | 16 | int:MEN1 |
| Interaction | RPL11 interactions | FANCD2 USP36 BDP1 RPL36AL RPL36A MAP1B ANLN H1-2 H1-6 SNAPC1 SSRP1 DDX21 KNOP1 | 1.92e-07 | 652 | 67 | 13 | int:RPL11 |
| Interaction | SMARCA1 interactions | 2.01e-07 | 188 | 67 | 8 | int:SMARCA1 | |
| Interaction | RPL31 interactions | FANCD2 USP36 ELOA TAF3 RPL36AL RPL36A ATAD5 ANLN H1-2 H1-6 DDX21 STT3B KNOP1 | 3.11e-07 | 680 | 67 | 13 | int:RPL31 |
| Interaction | PML interactions | FANCD2 ZNF148 WASHC2C UBN1 ATRX MAP1B ANLN NANOG RTF2 H1-2 TACC2 BRD1 PARP14 L3MBTL3 TRIM22 | 3.11e-07 | 933 | 67 | 15 | int:PML |
| Interaction | H2BC8 interactions | ELOA ZNF148 ATRX ATAD5 ANLN MPHOSPH8 CHD6 SSRP1 BRD1 DEK L3MBTL3 KNOP1 | 3.79e-07 | 576 | 67 | 12 | int:H2BC8 |
| Interaction | H2BC21 interactions | EPRS1 ATRX MAP1B ATAD5 H1-0 H1-2 H1-6 MPHOSPH8 SSRP1 BRD1 FMNL2 DEK L3MBTL3 | 4.04e-07 | 696 | 67 | 13 | int:H2BC21 |
| Interaction | LYAR interactions | 4.06e-07 | 373 | 67 | 10 | int:LYAR | |
| Interaction | H3C15 interactions | 4.20e-07 | 207 | 67 | 8 | int:H3C15 | |
| Interaction | H2AC14 interactions | 4.99e-07 | 144 | 67 | 7 | int:H2AC14 | |
| Interaction | NAA40 interactions | USP36 EPRS1 ELOA PTPN13 ZNF148 RPL36A WASHC2C ATRX MAP1B ATAD5 TACC2 SSRP1 DDX21 ADD1 KNOP1 | 5.66e-07 | 978 | 67 | 15 | int:NAA40 |
| Interaction | RBM19 interactions | 6.89e-07 | 221 | 67 | 8 | int:RBM19 | |
| Interaction | POLR2E interactions | 7.95e-07 | 308 | 67 | 9 | int:POLR2E | |
| Interaction | H2AC4 interactions | FANCD2 EPRS1 KMT2C USP51 ATRX ATAD5 H1-0 H1-2 H1-6 SSRP1 DDX21 | 8.10e-07 | 506 | 67 | 11 | int:H2AC4 |
| Interaction | H2BC3 interactions | 8.79e-07 | 406 | 67 | 10 | int:H2BC3 | |
| Interaction | CDC14B interactions | 9.34e-07 | 158 | 67 | 7 | int:CDC14B | |
| Interaction | RRP12 interactions | 1.09e-06 | 320 | 67 | 9 | int:RRP12 | |
| Interaction | NOP2 interactions | FANCD2 USP36 RPL36AL ANLN H1-2 MPHOSPH8 SSRP1 POLR1G DDX21 KNOP1 | 1.09e-06 | 416 | 67 | 10 | int:NOP2 |
| Interaction | MAK16 interactions | 1.10e-06 | 162 | 67 | 7 | int:MAK16 | |
| Interaction | RPF2 interactions | 1.13e-06 | 236 | 67 | 8 | int:RPF2 | |
| Interaction | SPOUT1 interactions | 1.15e-06 | 163 | 67 | 7 | int:SPOUT1 | |
| Interaction | MAP7D1 interactions | 1.15e-06 | 163 | 67 | 7 | int:MAP7D1 | |
| Interaction | EBNA1BP2 interactions | 1.21e-06 | 324 | 67 | 9 | int:EBNA1BP2 | |
| Interaction | NPM1 interactions | FANCD2 USP36 BDP1 EPRS1 TAF3 RPL36AL MAP1B ANLN H1-2 LTN1 LEMD1 SSRP1 BRD1 POLR1G DDX21 KNOP1 | 1.43e-06 | 1201 | 67 | 16 | int:NPM1 |
| Interaction | BRD2 interactions | 1.44e-06 | 429 | 67 | 10 | int:BRD2 | |
| Interaction | NIFK interactions | FANCD2 USP36 ELOA TAF3 RPL36AL ATAD5 ANLN POLR1G DDX21 KNOP1 | 1.51e-06 | 431 | 67 | 10 | int:NIFK |
| Interaction | NVL interactions | 1.59e-06 | 171 | 67 | 7 | int:NVL | |
| Interaction | MPHOSPH10 interactions | 1.78e-06 | 174 | 67 | 7 | int:MPHOSPH10 | |
| Interaction | SUPT16H interactions | 1.89e-06 | 442 | 67 | 10 | int:SUPT16H | |
| Interaction | PUM3 interactions | 1.96e-06 | 254 | 67 | 8 | int:PUM3 | |
| Interaction | CHD4 interactions | FANCD2 USP36 EPRS1 ELOA NANOG RBPJ H1-0 H1-2 RPS19BP1 SSRP1 BRD1 DDX21 DEK KNOP1 | 1.98e-06 | 938 | 67 | 14 | int:CHD4 |
| Interaction | H2BC9 interactions | 2.05e-06 | 446 | 67 | 10 | int:H2BC9 | |
| Interaction | H3-4 interactions | 2.13e-06 | 448 | 67 | 10 | int:H3-4 | |
| Interaction | FGFBP1 interactions | 2.14e-06 | 257 | 67 | 8 | int:FGFBP1 | |
| Interaction | H2BC4 interactions | 2.26e-06 | 259 | 67 | 8 | int:H2BC4 | |
| Interaction | NR2C2 interactions | EPRS1 TAF3 RPL36AL ZNF148 RPL36A UBN1 H1-0 H1-2 H1-6 CHD6 SSRP1 POLR1G DDX21 DEK ADD1 ADD2 KNOP1 | 2.30e-06 | 1403 | 67 | 17 | int:NR2C2 |
| Interaction | REXO4 interactions | 2.40e-06 | 261 | 67 | 8 | int:REXO4 | |
| Interaction | NOP56 interactions | FANCD2 USP36 ELOA ATRX ATAD5 ANLN SSRP1 POLR1G DDX21 DEK KNOP1 | 2.57e-06 | 570 | 67 | 11 | int:NOP56 |
| Interaction | PYHIN1 interactions | 2.75e-06 | 358 | 67 | 9 | int:PYHIN1 | |
| Interaction | REST interactions | 3.44e-06 | 274 | 67 | 8 | int:REST | |
| Interaction | RPL30 interactions | FANCD2 USP36 RPL36AL RPL36A ANLN H1-2 H1-6 SNAPC1 DDX21 KNOP1 | 3.52e-06 | 474 | 67 | 10 | int:RPL30 |
| Interaction | SDAD1 interactions | 3.55e-06 | 193 | 67 | 7 | int:SDAD1 | |
| Interaction | POP1 interactions | 3.72e-06 | 277 | 67 | 8 | int:POP1 | |
| Interaction | DDX21 interactions | FANCD2 USP36 RPL36AL MAP1B ANLN H1-2 H1-6 SSRP1 POLR1G DDX21 KIAA2012 DEK | 3.79e-06 | 718 | 67 | 12 | int:DDX21 |
| Interaction | NSD2 interactions | 3.82e-06 | 278 | 67 | 8 | int:NSD2 | |
| Interaction | DDX24 interactions | FANCD2 USP36 RPL36AL ANLN NANOG RBPJ H1-2 BRD1 POLR1G DDX21 KNOP1 | 3.95e-06 | 596 | 67 | 11 | int:DDX24 |
| Interaction | USP36 interactions | FANCD2 USP36 ELOA RPL36AL RPL36A H1-2 RPS19BP1 SSRP1 POLR1G DDX21 KNOP1 | 4.14e-06 | 599 | 67 | 11 | int:USP36 |
| Interaction | ADNP interactions | 4.34e-06 | 199 | 67 | 7 | int:ADNP | |
| Interaction | RPL5 interactions | FANCD2 USP36 RPL36AL RPL36A ANLN H1-0 SNAPC1 SSRP1 POLR1G DDX21 KNOP1 | 4.63e-06 | 606 | 67 | 11 | int:RPL5 |
| Interaction | PARP1 interactions | FANCD2 USP36 ELOA TAF3 PTPN13 ZNF148 ATAD5 ANLN NANOG H1-0 H1-2 CHD6 SSRP1 DDX21 STT3B KNOP1 | 4.69e-06 | 1316 | 67 | 16 | int:PARP1 |
| Interaction | BRD3 interactions | 5.07e-06 | 494 | 67 | 10 | int:BRD3 | |
| Interaction | BAZ1B interactions | 5.11e-06 | 204 | 67 | 7 | int:BAZ1B | |
| Interaction | RBM34 interactions | 5.22e-06 | 290 | 67 | 8 | int:RBM34 | |
| Interaction | H1-3 interactions | 5.35e-06 | 291 | 67 | 8 | int:H1-3 | |
| Interaction | NAP1L4 interactions | 5.45e-06 | 206 | 67 | 7 | int:NAP1L4 | |
| Interaction | RFC5 interactions | 5.45e-06 | 206 | 67 | 7 | int:RFC5 | |
| Interaction | DKC1 interactions | 5.86e-06 | 393 | 67 | 9 | int:DKC1 | |
| Interaction | BRPF1 interactions | 6.11e-06 | 78 | 67 | 5 | int:BRPF1 | |
| Interaction | H2BC13 interactions | 6.18e-06 | 210 | 67 | 7 | int:H2BC13 | |
| Interaction | IMP3 interactions | 6.28e-06 | 137 | 67 | 6 | int:IMP3 | |
| Interaction | CHD3 interactions | FANCD2 USP36 EPRS1 ELOA ATAD5 RBPJ H1-2 CHD6 SSRP1 BRD1 DDX21 KNOP1 | 6.50e-06 | 757 | 67 | 12 | int:CHD3 |
| Interaction | TENT4B interactions | 6.55e-06 | 138 | 67 | 6 | int:TENT4B | |
| Interaction | LLPH interactions | 6.82e-06 | 139 | 67 | 6 | int:LLPH | |
| Interaction | RPS19 interactions | FANCD2 USP36 RPL36AL MAP1B ANLN H1-2 RPS19BP1 H1-6 DDX21 STT3B KNOP1 | 7.65e-06 | 639 | 67 | 11 | int:RPS19 |
| Interaction | KPNA2 interactions | 7.82e-06 | 519 | 67 | 10 | int:KPNA2 | |
| Interaction | TOP2A interactions | FANCD2 USP36 RPL36A ANLN NANOG SSRP1 POLR1G DDX21 L3MBTL3 SPICE1 | 7.95e-06 | 520 | 67 | 10 | int:TOP2A |
| Interaction | RPL36AL interactions | 8.30e-06 | 309 | 67 | 8 | int:RPL36AL | |
| Interaction | SMARCA5 interactions | 9.08e-06 | 415 | 67 | 9 | int:SMARCA5 | |
| Interaction | GATAD2A interactions | 9.42e-06 | 224 | 67 | 7 | int:GATAD2A | |
| Interaction | KRI1 interactions | 9.70e-06 | 225 | 67 | 7 | int:KRI1 | |
| Interaction | H2AC18 interactions | 9.78e-06 | 148 | 67 | 6 | int:H2AC18 | |
| Interaction | RPS15 interactions | 1.06e-05 | 423 | 67 | 9 | int:RPS15 | |
| Interaction | H1-2 interactions | FANCD2 USP36 EPRS1 B3GLCT RPL36A ATRX NANOG H1-0 H1-2 H1-6 DDX21 | 1.13e-05 | 666 | 67 | 11 | int:H1-2 |
| Interaction | PPM1G interactions | 1.20e-05 | 325 | 67 | 8 | int:PPM1G | |
| Interaction | CTR9 interactions | 1.22e-05 | 233 | 67 | 7 | int:CTR9 | |
| Interaction | DOT1L interactions | EPRS1 RPL36AL ZNF148 RPL36A ATRX NANOG H1-2 SSRP1 POLR1G DDX21 DEK KNOP1 | 1.24e-05 | 807 | 67 | 12 | int:DOT1L |
| Interaction | PRG4 interactions | 1.25e-05 | 14 | 67 | 3 | int:PRG4 | |
| Interaction | DDX27 interactions | 1.31e-05 | 329 | 67 | 8 | int:DDX27 | |
| Interaction | RPL7A interactions | FANCD2 USP36 EPRS1 RPL36AL RPL36A ATRX ANLN H1-6 POLR1G DDX21 KNOP1 | 1.35e-05 | 679 | 67 | 11 | int:RPL7A |
| Interaction | RRP15 interactions | 1.37e-05 | 157 | 67 | 6 | int:RRP15 | |
| Interaction | PCID2 interactions | 1.37e-05 | 92 | 67 | 5 | int:PCID2 | |
| Interaction | RPL14 interactions | FANCD2 USP36 RPL36AL RPL36A MAP1B ANLN H1-6 SSRP1 DDX21 KNOP1 | 1.38e-05 | 554 | 67 | 10 | int:RPL14 |
| Interaction | GLYR1 interactions | 1.43e-05 | 239 | 67 | 7 | int:GLYR1 | |
| Interaction | RPL22 interactions | 1.45e-05 | 440 | 67 | 9 | int:RPL22 | |
| Interaction | SSRP1 interactions | FANCD2 USP36 ELOA ATRX ANLN NANOG MPHOSPH8 SSRP1 POLR1G DDX21 SPICE1 | 1.47e-05 | 685 | 67 | 11 | int:SSRP1 |
| Interaction | POLR2C interactions | 1.59e-05 | 338 | 67 | 8 | int:POLR2C | |
| Interaction | NOL10 interactions | 1.64e-05 | 162 | 67 | 6 | int:NOL10 | |
| Interaction | RRS1 interactions | 1.84e-05 | 345 | 67 | 8 | int:RRS1 | |
| GeneFamily | WASH complex | 9.44e-05 | 6 | 46 | 2 | 1331 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.43e-04 | 11 | 46 | 2 | 1168 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.17e-03 | 20 | 46 | 2 | 548 | |
| GeneFamily | PHD finger proteins | 1.55e-03 | 90 | 46 | 3 | 88 | |
| GeneFamily | Histones | 3.20e-03 | 116 | 46 | 3 | 864 | |
| GeneFamily | L ribosomal proteins | 7.46e-03 | 51 | 46 | 2 | 729 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.04e-03 | 53 | 46 | 2 | 532 | |
| GeneFamily | Ubiquitin specific peptidases | 8.94e-03 | 56 | 46 | 2 | 366 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 1.26e-02 | 67 | 46 | 2 | 519 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.54e-02 | 206 | 46 | 3 | 682 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 EPRS1 PTPN13 ZNF148 MYO9A ANLN MPHOSPH8 SNAPC1 DDX21 DEK | 5.38e-06 | 656 | 66 | 10 | M18979 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 EPRS1 TAF3 WASHC2C ATRX ATAD5 TRO BRD1 FANCM DEK KIAA0753 | 1.41e-06 | 564 | 67 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 2.62e-06 | 124 | 67 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | EPRS1 PTPN13 USP51 MAP1B ATAD5 MPHOSPH8 FANCM POLR1G DDX21 KNOP1 | 3.32e-06 | 496 | 67 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.64e-06 | 204 | 67 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 EPRS1 ELOA USP51 ATRX MAP1B MYO9A ATAD5 MPHOSPH8 ARMH3 FMNL2 DEK | 9.86e-06 | 831 | 67 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.19e-05 | 192 | 67 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 3.40e-05 | 396 | 67 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.36e-05 | 203 | 67 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | USP36 BDP1 EPRS1 PTPN13 USP51 MAP1B ATAD5 MPHOSPH8 FANCM POLR1G DDX21 KNOP1 | 5.58e-05 | 991 | 67 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 9.12e-05 | 232 | 67 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 1.68e-04 | 498 | 67 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | PTPN13 USP51 ATRX MAP1B ATAD5 KIF1B MPHOSPH8 FANCM FMNL2 DEK KNOP1 | 2.42e-04 | 986 | 67 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | USP36 EPRS1 RPL36AL PTPN13 ATAD5 NANOG MPHOSPH8 FANCM POLR1G DDX21 DEK KNOP1 | 2.54e-04 | 1164 | 67 | 12 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | USP36 EPRS1 RPL36AL PTPN13 MAP1B ATAD5 NANOG MPHOSPH8 FANCM POLR1G DDX21 DEK KNOP1 | 2.59e-04 | 1347 | 67 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.62e-04 | 532 | 67 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 2.72e-04 | 99 | 67 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.43e-04 | 191 | 67 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.54e-04 | 298 | 67 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 5.52e-04 | 595 | 67 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.87e-04 | 328 | 67 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.20e-04 | 123 | 67 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.63e-08 | 197 | 70 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.41e-07 | 200 | 70 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.60e-06 | 155 | 70 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 6.23e-06 | 165 | 70 | 5 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.41e-06 | 171 | 70 | 5 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 7.63e-06 | 172 | 70 | 5 | fb8ab2576b5c38db63573a3bf46b8d9d634c4999 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 8.29e-06 | 175 | 70 | 5 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-06 | 176 | 70 | 5 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 177 | 70 | 5 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | C_00|World / shred on cell type and cluster | 9.25e-06 | 179 | 70 | 5 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 9.76e-06 | 181 | 70 | 5 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.20e-05 | 189 | 70 | 5 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 192 | 70 | 5 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-05 | 193 | 70 | 5 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 1.54e-05 | 199 | 70 | 5 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.54e-05 | 199 | 70 | 5 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 1.54e-05 | 199 | 70 | 5 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-05 | 199 | 70 | 5 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-05 | 199 | 70 | 5 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-05 | 199 | 70 | 5 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.54e-05 | 199 | 70 | 5 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.54e-05 | 199 | 70 | 5 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | 00538c4cbab5da00b3a366717d38a3ba5cfe3f65 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.58e-05 | 200 | 70 | 5 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.58e-05 | 200 | 70 | 5 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Enterocyte-C_02|Enterocyte / shred on cell type and cluster | 6.27e-05 | 136 | 70 | 4 | daf11618c65e8fa2d77001b5c277d534cc012a4b | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 1.18e-04 | 160 | 70 | 4 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 1.21e-04 | 161 | 70 | 4 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 163 | 70 | 4 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 163 | 70 | 4 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 163 | 70 | 4 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 165 | 70 | 4 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.42e-04 | 168 | 70 | 4 | d50078614f7af74dc2aa4081c1708a5156ac51cf | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 180 | 70 | 4 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-04 | 181 | 70 | 4 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-04 | 181 | 70 | 4 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 181 | 70 | 4 | e0c46e2d52c97893e5894a51d2699e8a8a11eefc | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-04 | 184 | 70 | 4 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-04 | 184 | 70 | 4 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.01e-04 | 184 | 70 | 4 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-04 | 184 | 70 | 4 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.01e-04 | 184 | 70 | 4 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 187 | 70 | 4 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 2.18e-04 | 188 | 70 | 4 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 2.18e-04 | 188 | 70 | 4 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 2.18e-04 | 188 | 70 | 4 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 190 | 70 | 4 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-04 | 191 | 70 | 4 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 2.32e-04 | 191 | 70 | 4 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.32e-04 | 191 | 70 | 4 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.32e-04 | 191 | 70 | 4 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 191 | 70 | 4 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.32e-04 | 191 | 70 | 4 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 193 | 70 | 4 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.41e-04 | 193 | 70 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.41e-04 | 193 | 70 | 4 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.41e-04 | 193 | 70 | 4 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 2.46e-04 | 194 | 70 | 4 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 2.46e-04 | 194 | 70 | 4 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.46e-04 | 194 | 70 | 4 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.51e-04 | 195 | 70 | 4 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 195 | 70 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.51e-04 | 195 | 70 | 4 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 195 | 70 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 2.56e-04 | 196 | 70 | 4 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 2.56e-04 | 196 | 70 | 4 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 2.56e-04 | 196 | 70 | 4 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 2.56e-04 | 196 | 70 | 4 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 2.56e-04 | 196 | 70 | 4 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-04 | 196 | 70 | 4 | 36b4f08fc038dfde6343ff0869e1a027d882adb5 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 197 | 70 | 4 | e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.61e-04 | 197 | 70 | 4 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.61e-04 | 197 | 70 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.66e-04 | 198 | 70 | 4 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.66e-04 | 198 | 70 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-04 | 198 | 70 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | medial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.66e-04 | 198 | 70 | 4 | 071658de0c43f302172692aa0b4b507dbad7be50 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 2.66e-04 | 198 | 70 | 4 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-04 | 199 | 70 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 2.71e-04 | 199 | 70 | 4 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-04 | 199 | 70 | 4 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | remission-T/NK_proliferative|remission / disease stage, cell group and cell class | 2.71e-04 | 199 | 70 | 4 | 303a5fc43a48b05b6f2060d99eef4adc36f8d4e3 | |
| ToppCell | control-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-04 | 199 | 70 | 4 | 50e2da35edff1aadef939cfbd4549f73c1a07717 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-04 | 199 | 70 | 4 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 2.71e-04 | 199 | 70 | 4 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.71e-04 | 199 | 70 | 4 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.71e-04 | 199 | 70 | 4 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.71e-04 | 199 | 70 | 4 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 2.76e-04 | 200 | 70 | 4 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.76e-04 | 200 | 70 | 4 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.76e-04 | 200 | 70 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-04 | 200 | 70 | 4 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.76e-04 | 200 | 70 | 4 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | PBMC-Severe-cDC_9|Severe / Compartment, Disease Groups and Clusters | 2.76e-04 | 200 | 70 | 4 | ea3b22126d9dfd158bb3c3e1323b30514d721ded | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-04 | 200 | 70 | 4 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 2.76e-04 | 200 | 70 | 4 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | (5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.76e-04 | 200 | 70 | 4 | 948c55aa1c25f8a69b1bd3ef53fd32aa222f592c | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 2.76e-04 | 200 | 70 | 4 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.76e-04 | 200 | 70 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 2.76e-04 | 200 | 70 | 4 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| Computational | Genes in the cancer module 89. | 1.96e-05 | 14 | 42 | 3 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 3.00e-05 | 16 | 42 | 3 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 3.63e-05 | 17 | 42 | 3 | MODULE_90 | |
| Disease | spastic quadriplegic cerebral palsy 3 (implicated_via_orthology) | 1.30e-05 | 3 | 62 | 2 | DOID:0081361 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 3.23e-05 | 173 | 62 | 5 | C0023467 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.94e-05 | 90 | 62 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Fanconi anemia (implicated_via_orthology) | 1.21e-04 | 8 | 62 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | Neuroblastoma | 1.34e-04 | 47 | 62 | 3 | C0027819 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.93e-04 | 10 | 62 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | colon cancer (implicated_via_orthology) | 2.36e-04 | 11 | 62 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.85e-04 | 67 | 62 | 3 | C3463824 | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.19e-04 | 69 | 62 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Bone marrow hypocellularity | 6.50e-04 | 18 | 62 | 2 | C1855710 | |
| Disease | lung adenocarcinoma (is_marker_for) | 7.72e-04 | 85 | 62 | 3 | DOID:3910 (is_marker_for) | |
| Disease | Adenoid Cystic Carcinoma | 1.24e-03 | 100 | 62 | 3 | C0010606 | |
| Disease | Fanconi Anemia | 1.26e-03 | 25 | 62 | 2 | C0015625 | |
| Disease | Acute monocytic leukemia | 1.37e-03 | 26 | 62 | 2 | C0023465 | |
| Disease | Pancytopenia | 1.37e-03 | 26 | 62 | 2 | C0030312 | |
| Disease | Miller Dieker syndrome | 1.70e-03 | 29 | 62 | 2 | C0265219 | |
| Disease | IgA glomerulonephritis (is_implicated_in) | 1.82e-03 | 30 | 62 | 2 | DOID:2986 (is_implicated_in) | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 2.07e-03 | 32 | 62 | 2 | EFO_0021870 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FKVKMTTPLKKLKKS | 36 | G2XKQ0 | |
| RISTPKKSKKKSNKR | 661 | Q96QE3 | |
| ISKAPKKTKIKLTKI | 406 | Q96M60 | |
| VRKKAKKAKKALAEP | 426 | O95696 | |
| LKEKKSTKPRKNVKV | 391 | A6H8Y1 | |
| RKPVKKKDIFVAVKT | 261 | Q6Y288 | |
| PKKSVAFKKTKKEIK | 101 | P07305 | |
| AFKKTKKEIKKVATP | 106 | P07305 | |
| KKEIKKVATPKKASK | 111 | P07305 | |
| VTKKVAKSPKKAKVA | 166 | P16403 | |
| LRKSSASKKPLKEKV | 11 | Q5T2E6 | |
| KKKTSRGKKRLKPVL | 6 | Q8IWG1 | |
| RKACDRPVAKTKKKK | 101 | Q86WX3 | |
| FVDTKKLPIIKKKVR | 641 | Q96SU4 | |
| KKLKKWPEASTTKRK | 86 | Q68G75 | |
| RKKKPKLSLKADTKE | 171 | Q96JM7 | |
| VLQKPKSSLKSSKKK | 521 | O94822 | |
| IIPEEKGKKKRTRKK | 3596 | Q8NEZ4 | |
| KKDLKEKTKTKKPGT | 2236 | P46821 | |
| HRTTKVKKSPKVRKK | 1316 | A6NMS7 | |
| CTSKSKKKKKTDFIP | 291 | O60333 | |
| KKKTSKSKAITPKRL | 896 | Q9NQW6 | |
| KPTKIVSLKKKVSKE | 846 | Q8IYD8 | |
| NIKKSDKSFKRKKPT | 16 | P0DPP9 | |
| KKEDKVPVKKQKTRT | 86 | Q9H9S0 | |
| SKAKKKLEKKTRPQR | 871 | Q0VF49 | |
| KKKKKVVKEPETRYS | 16 | Q1ED39 | |
| QTKPIFRKKAKTTKK | 51 | Q969Q0 | |
| LKTEKKLFWPKIKKV | 686 | Q460N5 | |
| KEKQKLSVPVRKKDK | 686 | P46100 | |
| LSKKVIPKSTRSKAK | 111 | P22492 | |
| KTKKLVLSRDSKSPK | 131 | P22492 | |
| QPRKKKKKIVKTSAT | 441 | Q14241 | |
| TPVEKKKKGKRKSET | 191 | Q8TD26 | |
| KREKPKQKATSKSKK | 261 | P35659 | |
| LAAVKIKKPIKTKFR | 611 | Q96PY5 | |
| NIKKSDKSFKRKKPT | 16 | Q3ZM63 | |
| RKKKEPIEKKVVSSK | 96 | Q9NR30 | |
| RKVPEVTEKKNKKLK | 6 | Q9BRJ6 | |
| EVKTRKPKKKTRKPS | 356 | P0C7A2 | |
| SKTRKQPLSKKTKKS | 21 | Q9BXW9 | |
| EDTSPKKKKKKLRQR | 146 | Q99549 | |
| RETKKISFSKKKITL | 821 | Q12923 | |
| EFLKVSSKKKKTQPK | 936 | Q99683 | |
| LRAKLEKKTKKPKAA | 191 | Q9BY42 | |
| KRISKKKTHVKKCTP | 336 | Q9H2B2 | |
| KTFKKGKKKESPVIS | 571 | Q8TDW5 | |
| PSSVEVKKKLKKELK | 516 | Q5VWG9 | |
| KKRFRKTQKKVPDVK | 231 | Q5H9L4 | |
| VVRKLKAEKSPKAKI | 836 | P07814 | |
| AKKKTKVARKSLDPL | 166 | Q9H426 | |
| QTKPIFRKKAKTTKK | 51 | P83881 | |
| KKEDKVPVKKQKTRT | 86 | Q6NSW7 | |
| AAPTSTKKKKKKKER | 416 | O15446 | |
| ESLLEKKLSPKKVKK | 371 | Q2KHM9 | |
| KKLSPKKVKKCFSEI | 376 | Q2KHM9 | |
| RKTPKVKKKKTSVKQ | 16 | Q8N0Z3 | |
| VKATRKKEKKERLKP | 301 | Q16533 | |
| AKDRKSRKKPVEVKK | 526 | Q08945 | |
| TPSFLKKSKKKEKVE | 711 | P35612 | |
| KFRTPSFLKKSKKKS | 721 | P35611 | |
| VKKKAKPKKCARRFT | 391 | Q9H4F8 | |
| VKPKKKRRKKSVYTV | 346 | Q70EK9 | |
| PKKSKTKKAPIKTIT | 66 | Q12816 | |
| LITSIKPKKASKAKK | 196 | Q12816 | |
| FPKQKYLSKKTTKRK | 791 | Q8TCJ2 | |
| PKEKSKKKVEAKSIF | 1256 | Q9Y4E1 | |
| KKKTPLKTDTFRVKK | 2421 | O95359 | |
| FLSKRIKVISKPSKK | 156 | Q06330 | |
| IKVISKPSKKKQSLK | 161 | Q06330 | |
| ADLTVKPKEKSKKKV | 1271 | Q641Q2 | |
| KPKEKSKKKVEAKSI | 1276 | Q641Q2 | |
| KIKVKESSTKPDKKV | 596 | Q9NPG3 | |
| SLPKKKRQKTEKKSS | 311 | Q9UQR1 | |
| SWTLKKPKSVSKKLK | 261 | Q8IYM9 | |
| KPKSVSKKLKSVFRV | 266 | Q8IYM9 | |
| LKKKPKVRFTVDKKV | 166 | Q5VZQ5 | |
| ESPRKKKKKKRKQET | 951 | Q9P275 | |
| TKVPKTERKKRRKKE | 1976 | B2RTY4 |